$Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials$

Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials

Highlights • Brivaracetam was effect for refractory partial seizure in the present study. • Brivaracetam was well tolerated in the present study. • Long-term efficacy and safety of brivaracetam should be further investigated.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Epilepsy research 2015-08, Vol.114, p.59-65
Hauptverfasser:	Ma, Junpeng, Huang, Siqing, You, Chao
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anticonvulsants - adverse effects Anticonvulsants - therapeutic use Antiepileptic drug Brivaracetam Drug Resistant Epilepsy - drug therapy Drug Therapy, Combination Epilepsies, Partial - drug therapy Epilepsy Female Humans Male Middle Aged Neurology Pyrrolidinones - adverse effects Pyrrolidinones - therapeutic use Randomized Controlled Trials as Topic Seizures
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • Brivaracetam was effect for refractory partial seizure in the present study. • Brivaracetam was well tolerated in the present study. • Long-term efficacy and safety of brivaracetam should be further investigated.
ISSN:	0920-1211 1872-6844
DOI:	10.1016/j.eplepsyres.2015.04.017